Basel is evolving into a pediatrics hub
The Botnar Research Center for Child Health in Basel has started its research activities. The first four projects have now been selected. Together with the DayOne Accelerator from BaselArea.swiss, Basel is gradually evolving into a pediatrics hub.
Children should benefit from research in Basel (img: Creative Commons)
The Botnar Research Center for Child Health (BRCCH) aims to foster novel and innovative research in pediatrics, a field in which the center benefits from partnerships with the University of Basel, the University Children’s Hospital Basel, the Swiss Tropical and Public Health Institute (Swiss TPH) and the Federal Institute of Technology in Zurich (ETH), according to a statement. On January 30, 2020, the BRCCH is hosting its first Spotlight Day in Basel, where it will showcase the four research projects that are kickstarting the center’s activities.
One project features an app with a digital medical system that can support the wellbeing of infants and young children growing up in rural areas of low-and middle-income countries. The platform is being assessed via a study of 2,400 children in Peru. Children with cleft lip or palate are the focus of the second project, which seeks to optimize surgical treatment with the use of artificial intelligence, smartphone-based images and 3D-printing of orthopedic plates.
For the third project, researchers are examining gut floral to fight infection and inflammatory disease in children. Using a CRISPR-based technology, they aim to develop bacteria that will provide assessments of the gut to improve the health of affected children. Gut bacteria are also the focus of the fourth project, which plans to replace “bad” bacteria with useful bacteria. This modification will be achieved with the help of engineered antibodies, and the direct targeting of individual genes in intestine-resident bacteria by employing CRISPR-Cas9 methodology.
The research activities at the BRCCH cement Basel’s growing reputation as a pediatrics hub. The city’s location promotion organization BaselArea.swiss is also using its DayOne Accelerator to support Digital Health startups that are working to improve the health of children and young people. Participants for the second round were recently announced.
Share this article
You might also be interested in
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.Read More
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.Read More
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.Read More
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.Read More
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.Read More
We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.Read More